|
Market Closed -
Nasdaq
16:00:00 2026-09-08 EDT
|
5-day change | 1st Jan Change | ||
| 5.390 USD | -4.09% |
|
-6.59% | -53.73% |
| 08-13 | ARS Pharmaceuticals Q2 Net Loss Widens, Revenue Rises | MT |
| 08-13 | ARS Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 13, 2026 |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -4.09% | -6.59% | -12.50% | -40.04% | -53.73% | -49.63% | -26.87% | - | - | 536M | |
| -0.79% | -3.77% | -2.83% | +13.63% | +3.38% | -2.49% | +14.92% | -27.75% | +199.73% | 48.01B | |
| -1.29% | -1.22% | +1.06% | +39.62% | +160.29% | +404.92% | +545.45% | +584.68% | - | 44.44B | |
| -3.20% | +0.33% | +8.59% | +41.11% | +14.99% | +38.11% | +21.39% | -1.03% | +232.96% | 42.67B | |
| -1.89% | -2.00% | +0.92% | +29.79% | +15.69% | +1.45% | +82.46% | +2.58% | +1,012.98% | 39.96B | |
| -1.72% | -2.61% | -8.13% | +14.87% | +6.22% | +13.09% | +42.33% | -18.57% | +139.05% | 32.75B | |
| -0.17% | +3.78% | +5.75% | +31.23% | - | - | - | - | - | 17.74B | |
| -0.07% | +1.32% | +0.04% | +29.04% | +5.21% | +20.08% | +117.95% | +207.71% | +1,866.36% | 16.49B | |
| -0.28% | -2.36% | +1.46% | +9.36% | +13.88% | +11.10% | +31.16% | -42.75% | +88.59% | 14.38B | |
| -2.68% | -0.56% | +4.96% | +50.59% | +40.75% | +73.31% | +40.56% | -36.98% | +244.28% | 13.4B | |
| -3.95% | -1.90% | -3.75% | +4.01% | -13.11% | -10.95% | -36.70% | -39.06% | +107.20% | 12.22B | |
| -0.51% | +3.24% | +23.52% | +32.31% | +8.87% | -19.86% | - | - | - | 11.6B | |
| -0.17% | +0.18% | +0.03% | +37.34% | +22.96% | +33.64% | +0.68% | -43.04% | +161.71% | 11.34B | |
| +3.64% | +0.38% | -5.57% | +93.40% | +50.40% | +31.17% | +58.14% | -48.92% | - | 10.74B | |
| 0.00% | +4.50% | -9.09% | +17.72% | -16.11% | +32.20% | +504.07% | +181.73% | +2,444.08% | 10.24B | |
| +0.19% | -0.27% | -2.30% | +39.18% | +19.59% | +764.98% | +1,590.55% | +15.81% | - | 9.84B | |
| -0.78% | -2.17% | +8.32% | +57.50% | +49.69% | +169.23% | +514.94% | +85.61% | - | 9.68B | |
| -2.38% | -5.29% | +0.27% | -22.89% | -28.32% | -7.03% | +37.61% | +53.39% | +83.94% | 9.42B | |
| +0.15% | -0.38% | +0.05% | +48.87% | +67.09% | +159.73% | +666.09% | +214.73% | +1,061.02% | 9.44B | |
| -2.51% | -2.33% | +0.19% | +16.97% | -10.47% | -15.38% | -8.66% | -32.21% | +36.17% | 8.76B | |
| Average | -1.12% | -0.78% | +0.55% | +27.18% | +18.80% | +86.72% | +233.12% | +62.11% | +590.62% | 18.68B | |
| Weighted average by Cap. | -1.27% | -0.87% | +0.99% | +29.54% | +31.15% | +91.56% | +191.75% | +87.32% | +517.26% |
- Stock Market
- Stocks
- SPRY Stock
- Sector ARS Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
